Cargando…
Current Treatment for Low-Risk Prostate Cancer in China: A National Network Survey
Objective: To analyze the current treatment for low-risk prostate cancer (LRPC) in China. Methods: A national questionnaire survey titled “A survey of current treatment of LRPC” was designed and released nationally through the network from July 16 to August 3, 2017. Results: A total of 1,116 valid q...
Autores principales: | Wei, Yongbao, Liu, Longfei, Li, Xin, Song, Wei, Zhong, Dewen, Cao, Xiande, Yuan, Daozhang, Ming, Shaoxiong, Zhang, Peng, Wen, Yanlin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6485215/ https://www.ncbi.nlm.nih.gov/pubmed/31031859 http://dx.doi.org/10.7150/jca.29595 |
Ejemplares similares
-
National survey on current situation of critical value reporting in 973 laboratories in China
por: Fei, Yang, et al.
Publicado: (2017) -
Androgen deprivation therapy plus apalutamide as neoadjuvant therapy prior radical prostatectomy for patients with unresectable prostate cancer
por: Wei, Yongbao, et al.
Publicado: (2023) -
The Current Situation of Anaesthesia for Hysteroscopy in Mainland China: A National Survey
por: Huang, Lili, et al.
Publicado: (2023) -
Investigation of awareness rate of prostate-specific antigen (PSA) among the general public in China and analysis of influencing factors
por: Wang, Yuqin, et al.
Publicado: (2023) -
Efficacy and safety of transurethral split of prostate for benign prostatic hyperplasia: a meta-analysis
por: Huang, Yiyu, et al.
Publicado: (2020)